OMER Next Earnings Date Notes

— Omeros Corporation (OMER) is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated disorders, & central nervous system (CNS) diseases. The company’s most notable marketed product has been OMIDRIA® (phenylephrine and ketorolac intraocular solution), used in cataract surgery to maintain pupil size and reduce postoperative pain, though rights were sold in 2021, meaning future revenue streams now depend on the development pipeline. Key clinical assets include narsoplimab, a MASP-2 inhibitor targeting conditions like hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) & IgA nephropathy, both areas with significant unmet need. The most relevant business metrics to follow are pipeline clinical milestones (especially for narsoplimab), regulatory updates, cash runway & operational cash burn rate, partnership/licensing deals, and progress on new product candidates. As you listen to the next earnings call, pay close attention to management's commentary regarding regulatory paths, clinical trial timing, and how the company plans to fund operations and bring new therapies to market as revenue from OMIDRIA® winds down. The next projected earnings date for OMER is 5/14/2026 after close (stay tuned for a confirmed earnings date once announced).

OMER Next Earnings Date FAQ

On this page we presented the OMER Next Earnings Date information for Omeros along with recent past earnings dates. For Q4 of 2025, OMER reported earnings of 3.140/share, with the earnings report taking place on 3/31/2026. For Q3 of 2025, OMER reported earnings of -0.340/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, OMER reported earnings of -0.430/share, with the earnings report taking place on 8/14/2025. For Q1 of 2025, OMER reported earnings of -0.580/share, with the earnings report taking place on 5/15/2025. For Q4 of 2024, OMER reported earnings of -0.630/share, with the earnings report taking place on 3/31/2025. Based on these past earnings dates, the projected next earnings date for OMER is 5/14/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Omeros. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Omeros shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Omeros next earnings dates as well as any other stock out there in our coverage universe, to see when the next OMER earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up OMER's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the OMER next earnings date.